Podcasts / Management of stress urinary incontinence
Save
0.5 hours
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
0.5 hours
These are activities that require reflection on feedback about your work.
0 hours
These are activities that use your work data to ensure quality results.
Educational Activities (EA)
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
Reviewing Performance (RP)
These are activities that require reflection on feedback about your work.
Measuring Outcomes (MO)
These are activities that use your work data to ensure quality results.
In this episode:
– How Stress Urinary Incontinence is common, with up to 30% of women experiencing this
– How 70% will improve, or be cured, if referred early to a pelvic floor physiotherapist in about three months
– Those experiencing severe symptoms have a range of non-mesh surgical options, and all these options must be offered to the patients who need to intensify their treatment
Guest: Dr Jerome Melon, Urogynaecologist and Reconstructive Pelvic Surgeon
Host: Dr David Lim, GP and Medical Educator
Total time: 29 mins
Multiple Sclerosis vs Antibody Disease – What GPs Need to Know
Using SGLT2 to Reduce Cardiovascular Death in T2D – Important Updates for GPs
Menopause and MHT: Maximising Benefits & Minimising Risks
Peripheral Arterial Disease
expert
Urogynaecologist and Reconstructive Pelvic Surgeon; Urogynaecologist, Gold Coast University Hospital and The Queensland Pelvic Mesh Service; Consultant, Pindara Private Hospital, Greenslopes Private Hospital (Brisbane)
Browse the latest podcasts from Healthed.
You have completed the Educational Activities (EA) component of this activity.
Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.
You will be taken to explore further CPD learning available to you.
Menopause and MHT
Multiple sclerosis vs antibody disease
Using SGLT2 to reduce cardiovascular death in T2D
Peripheral arterial disease